{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:32:05Z","timestamp":1792690325685,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020295","name":"Natera","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004674","name":"Thermo Fisher Scientific Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.healun.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:07:21Z","timestamp":1773421641000},"page":"1046-1057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparing DSA-negative and DSA-positive antibody-mediated rejection in heart transplants: Results from the Trifecta-Heart study"],"prefix":"10.1016","volume":"45","author":[{"given":"Katelynn S.","family":"Madill-Thomsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis G.","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Mackova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach","family":"Demko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Prewett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Felius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Kuczaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neville","family":"Maliakkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojt\u011bch","family":"Melenovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Olympios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Przybylowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Sayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Tseliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Uriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Stehlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip F.","family":"Halloran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2026.03.004_bib1","first-page":"127","article-title":"Arteriolar vasculitis on endomyocardial biopsy: a histologic predictor of poor outcome in cyclosporine-treated heart transplant recipients","volume":"6","author":"Herskowitz","year":"1987","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib2","first-page":"430","article-title":"Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications","volume":"8","author":"Hammond","year":"1989","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.healun.2024.08.017","article-title":"Clinical outcomes after a biopsy diagnosis of antibody-mediated rejection in pediatric heart transplant recipients","volume":"44","author":"Everitt","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102614","article-title":"Contemporary antibody-mediated rejection in heart transplantation: JACC: heart failure position statement","volume":"13","author":"Mehta","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2026.03.004_bib5","article-title":"Antibody-mediated rejection: an evolving entity in heart transplantation","volume":"2012","author":"Chih","year":"2012","journal-title":"J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib6","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.healun.2016.04.007","article-title":"The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection","volume":"35","author":"Clerkin","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib7","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIR.0000000000000093","article-title":"Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association","volume":"131","author":"Colvin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2026.03.004_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2025.02.1690","article-title":"Summary of the International Society for Heart and Lung Transplantation consensus conference on emerging understanding of antibodies and antibody-mediated rejection in heart transplantation","volume":"44","author":"Kobashigawa","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib10","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ajt.2024.03.031","article-title":"Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival","volume":"24","author":"Halloran","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib11","first-page":"659","article-title":"Defining the relationships among four tests for assessing antibody-mediated rejection in heart transplants in a prospective, observational study","author":"Madill-Thomsen","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib12","doi-asserted-by":"crossref","first-page":"7474","DOI":"10.3390\/jcm12237474","article-title":"De novo donor-specific antibodies after heart transplantation: a comprehensive guide for clinicians","volume":"12","author":"Marco","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.healun.2026.03.004_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1550779","article-title":"Identification of a novel biomarker of antibody-mediated rejection in heart transplantation: synergistic effect of anti-nuclear antibodies and de novo donor-specific IgG HLA antibodies","volume":"16","author":"Misra","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.healun.2026.03.004_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.011592","article-title":"Redefining cardiac antibody-mediated rejection with donor-specific antibodies and graft dysfunction","volume":"17","author":"Goldberg","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2026.03.004_bib15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.healun.2015.10.035","article-title":"ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: a\u00a0retrospective validation analysis","volume":"35","author":"Hammond","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib16","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.healun.2010.05.025","article-title":"Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy","volume":"29","author":"Nath","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib17","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.ajt.2025.07.2476","article-title":"Non-human leukocyte antigen autoantibodies-anti-angiotensin II type 1 receptor and endothelin type A receptor antibodies-in the diagnosis of antibody-mediated rejection: biopsy-based transcript diagnostics perspective","author":"Harmacek","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib18","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41591-025-03653-3","article-title":"Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies","volume":"31","author":"Diebold","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.healun.2026.03.004_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized phase 2 trial of felzartamab in antibody-mediated rejection","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2026.03.004_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/tan.15458","article-title":"Daratumumab treatment in six highly sensitised solid organ transplant recipients: a case series and literature review","volume":"103","author":"Lemal","year":"2024","journal-title":"HLA"},{"key":"10.1016\/j.healun.2026.03.004_bib21","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/TP.0000000000003505","article-title":"Daratumumab for antibody-mediated rejection in heart transplant-a novel therapy: successful treatment of antibody-mediated rejection","volume":"105","author":"Aguilera Agudo","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2026.03.004_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688301","article-title":"HLA desensitization in solid organ transplantation: anti-CD38 to across the immunological barriers","volume":"12","author":"Joher","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.healun.2026.03.004_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/petr.70137","article-title":"CD38 in the crosshairs: daratumumab's emerging role in pediatric heart transplant care","volume":"29","author":"Gokanapudy Hahn","year":"2025","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib24","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1097\/TP.0000000000004986","article-title":"Comparing plasma donor-derived cell-free DNA to gene expression in endomyocardial biopsies in the Trifecta-Heart study","volume":"108","author":"Halloran","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2026.03.004_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1681\/ASN.2021091191","article-title":"The Trifecta study: comparing plasma levels of donor-derived cell-free DNA with the molecular phenotype of kidney transplant biopsies","volume":"33","author":"Halloran","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2026.03.004_bib26","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.ajt.2025.04.021","article-title":"A two-threshold algorithm using donor-derived cell-free DNA fraction and quantity to detect acute rejection after heart transplantation","volume":"25","author":"Kim","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib27","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1111\/ajt.14329","article-title":"Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX study","volume":"17","author":"Halloran","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib28","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"\u201cNatural\u201d human leukocyte antigen antibodies found in nonalloimmunized healthy males","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2026.03.004_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/TP.0000000000004324","article-title":"Antibody-mediated rejection without detectable donor-specific antibody releases donor-derived cell-free DNA: results from the Trifecta Study","volume":"107","author":"Halloran","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2026.03.004_bib30","unstructured":"RefPlus: a function set for the extrapolation strategy (RMA+) and extrapolation averaging (RMA++) methods. Version R package version 1.34.0;\u00a02014."},{"key":"10.1016\/j.healun.2026.03.004_bib31","unstructured":"Team RC. R: a language and environment for statistical computing. R Foundation for Statistical Computing. Available at:\u00a0http:\/\/www.r-project.org\/."},{"key":"10.1016\/j.healun.2026.03.004_bib32","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1111\/ajt.14200","article-title":"Comprehensive analysis of transcript changes associated with allograft rejection: combining universal and selective features","volume":"17","author":"Halloran","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1600-6143.2007.02129.x","article-title":"The transcriptome of human cytotoxic T cells: measuring the burden of CTL-associated transcripts in human kidney transplants","volume":"8","author":"Hidalgo","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib34","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1600-6143.2011.03970.x","article-title":"Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies","volume":"12","author":"Hidalgo","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib35","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1600-6143.2008.02232.x","article-title":"Expression of B cell and immunoglobulin transcripts is a feature of inflammation in late allografts","volume":"8","author":"Einecke","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib36","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1681\/ASN.2011090887","article-title":"Molecular phenotypes of acute kidney injury in human kidney transplants","volume":"23","author":"Famulski","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2026.03.004_bib37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2007.02118.x","article-title":"Interferon-gamma and donor MHC class I control alternative macrophage activation and activin expression in rejecting kidney allografts: a shift in the Th1-Th2 paradigm","volume":"8","author":"Famulski","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib38","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1600-6143.2009.03007.x","article-title":"Defining the canonical form of T-cell-mediated rejection in human kidney transplants","volume":"10","author":"Famulski","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib39","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/ajt.17092","article-title":"Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: Differences in timing and intensity but similar mechanisms and outcomes","volume":"22","author":"Halloran","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib40","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/ajt.14600","article-title":"Review: The transcripts associated with organ allograft rejection","volume":"18","author":"Halloran","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib41","article-title":"Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes","volume":"2","author":"Reeve","year":"2017","journal-title":"JCI\u00a0Insight"},{"key":"10.1016\/j.healun.2026.03.004_bib42","article-title":"Targeting CD38 in antibody-mediated rejection","volume":"38","author":"Mayer","year":"2025","journal-title":"Transpl\u00a0Int"},{"key":"10.1016\/j.healun.2026.03.004_bib43","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ajt.2023.12.005","article-title":"Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation","volume":"24","author":"Diebold","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib44","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/TP.0000000000001586","article-title":"Direct evidence for CD16a-mediated NK cell stimulation in antibody-mediated kidney transplant rejection","volume":"101","author":"Parkes","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2026.03.004_bib45","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1097\/TP.0000000000004231","article-title":"Assessing the relationship between molecular rejection and parenchymal injury in heart transplant biopsies","volume":"106","author":"Madill-Thomsen","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2026.03.004_bib46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1681\/ASN.2020040433","article-title":"Missing self-induced activation of NK cells combines with non-complement-fixing donor-specific antibodies to accelerate kidney transplant loss in chronic antibody-mediated rejection","volume":"32","author":"Koenig","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2026.03.004_bib47","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1038\/s41467-019-13113-5","article-title":"Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants","volume":"10","author":"Koenig","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.healun.2026.03.004_bib48","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1681\/ASN.2020111558","article-title":"Missing self-induced microvascular rejection of kidney allografts: a population-based study","volume":"32","author":"Callemeyn","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2026.03.004_bib49","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1111\/ajt.12438","article-title":"Kidney intragraft donor-specific antibodies as determinant of antibody-mediated lesions and poor graft outcome","volume":"13","author":"Bachelet","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib50","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/1074-7613(95)90069-1","article-title":"Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer","volume":"3","author":"Wagtmann","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.healun.2026.03.004_bib51","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/ndt\/gfaf097","article-title":"Antibody-mediated rejection - treatment standard","author":"Bohmig","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib52","doi-asserted-by":"crossref","first-page":"S698","DOI":"10.1016\/j.ajt.2025.07.1641","article-title":"Trial design of the phase 2 study SHAMROCK evaluating the safety, tolerability, and efficacy of efgartigimod PH20 SC in adult kidney transplant recipients with antibody-mediated rejection","volume":"25","author":"Bohmig","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.03.004_bib53","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1172\/JCI97911","article-title":"Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans","volume":"128","author":"Ulrichts","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2026.03.004_bib54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajt.2024.07.034","article-title":"Subthreshold rejection activity in many kidney transplants currently classified as having no rejection","volume":"25","author":"Halloran","year":"2025","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.03.004_bib55","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.ajt.2023.06.018","article-title":"Daratumumab for antibody-mediated rejection: is it time to target the real culprit?","volume":"23","author":"de Nattes","year":"2023","journal-title":"Am J Transpl"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249826017717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249826017717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:31:55Z","timestamp":1780403515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249826017717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1053249826017717"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2026.03.004","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing DSA-negative and DSA-positive antibody-mediated rejection in heart transplants: Results from the Trifecta-Heart study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}